Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Sorrento is well on its way to becoming the "go-to" company to conquer Covid . COVI-GUARD, COVI-SHIELD , and COVIDTRAP are all proceeding as rapidly as possible. And Sorrento has 4 more Covid technologies to be heard from. Sorrento's technologies apply to extremely sick patients, the immuno-compromised, and the elderly and cover both critical care treatment and prevention. And it has a base value in non-opioid pain and cancer treatments that analysts agree is worth more than $20 a share. And insiders own 34% of the shares. I like its chances.